Cargando…

Cathepsin K: A Novel Diagnostic and Predictive Biomarker for Renal Tumors

SIMPLE SUMMARY: Our understanding of renal tumors has increased in the last years with the description of several novel entities. The expanding morphological spectrum complicates the pathologist’s diagnosis, often requiring immunohistochemical analysis. The role of cathepsin K immunoexpression is wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caliò, Anna, Brunelli, Matteo, Gobbo, Stefano, Argani, Pedram, Munari, Enrico, Netto, George, Martignoni, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157838/ https://www.ncbi.nlm.nih.gov/pubmed/34069976 http://dx.doi.org/10.3390/cancers13102441

Ejemplares similares

MiT Family Translocation Renal Cell Carcinoma: from the Early Descriptions to the Current Knowledge
por: Caliò, Anna, et al.
Publicado: (2019)

TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms
por: Caliò, Anna, et al.
Publicado: (2022)

WHO 2022 Classification of Kidney Tumors: what is relevant? An update and future novelties for the pathologist
por: Caliò, Anna, et al.
Publicado: (2023)

STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma
por: Marletta, Stefano, et al.
Publicado: (2023)

Epithelioid angiomyolipoma: a pathological entity discovered in Verona with the endorsement of Doctor Rosai
por: Caliò, Anna, et al.
Publicado: (2021)

Report of two primary renal tumors with myxoid features. Differential diagnosis between benign and malignant entities
por: Fioravanzo, Adele, et al.
Publicado: (2021)

PD-1/PD-L1 in Cancer: Pathophysiological, Diagnostic and Therapeutic Aspects
por: Munari, Enrico, et al.
Publicado: (2021)

Comparison of three validated PD-L1 immunohistochemical assays in urothelial carcinoma of the bladder: interchangeability and issues related to patient selection
por: Munari, Enrico, et al.
Publicado: (2022)

iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona
por: Brunelli, Matteo, et al.
Publicado: (2014)

High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins
por: Zheng, Xiaoyong, et al.
Publicado: (2014)

Impact of PD-L1 and PD-1 Expression on the Prognostic Significance of CD8(+) Tumor-Infiltrating Lymphocytes in Non-Small Cell Lung Cancer
por: Munari, Enrico, et al.
Publicado: (2021)

Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells “in vitro” and correlating with progression “in vivo”
por: Perico, Maria Elisa, et al.
Publicado: (2016)

Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder
por: Massari, Francesco, et al.
Publicado: (2015)

PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
por: Munari, Enrico, et al.
Publicado: (2017)

Correction: PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
por: Munari, Enrico, et al.
Publicado: (2018)

PD-L1 expression comparison between primary and relapsed non-small cell lung carcinoma using whole sections and clone SP263
por: Munari, Enrico, et al.
Publicado: (2018)

Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives
por: Mijanović, Olja, et al.
Publicado: (2022)

GPNMB expression identifies TSC1/2/mTOR‐associated and MiT family translocation‐driven renal neoplasms
por: Salles, Daniela C, et al.
Publicado: (2022)

True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs
por: Brunelli, Matteo, et al.
Publicado: (2012)

Similarities and Differences between Clear Cell Tubulo-Papillary and Conventional Clear Cell Renal Cell Carcinoma: A Comparative Phenotypical and Mutational Analysis
por: Giunchi, Francesca, et al.
Publicado: (2020)

Cathepsin K: A Versatile Potential Biomarker and Therapeutic Target for Various Cancers
por: Qian, Die, et al.
Publicado: (2022)

Plasma Cathepsin S and Cathepsin S/Cystatin C Ratios Are Potential Biomarkers for COPD
por: Nakajima, Takahiro, et al.
Publicado: (2016)

Cathepsin K: The Action in and Beyond Bone
por: Dai, Rongchen, et al.
Publicado: (2020)

Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems
por: Marletta, Stefano, et al.
Publicado: (2022)

Suppression of cathepsin K biomarker in synovial fluid as a free-drug–driven process
por: Ma, Bennett, et al.
Publicado: (2019)

Technical and Diagnostic Issues in Whole Slide Imaging Published Validation Studies
por: Rizzo, Paola Chiara, et al.
Publicado: (2022)

Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
por: Porcaro, Antonio Benito, et al.
Publicado: (2015)

A composite docking approach for the identification and characterization of ectosteric inhibitors of cathepsin K
por: Law, Simon, et al.
Publicado: (2017)

Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer
por: Andrade, Sheila Siqueira, et al.
Publicado: (2016)

FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma
por: Brunello, Eleonora, et al.
Publicado: (2012)

Matrix-metalloproteinase-9 is cleaved and activated by Cathepsin K
por: Christensen, Jon, et al.
Publicado: (2015)

Advances in the discovery of cathepsin K inhibitors on bone resorption
por: Lu, Jun, et al.
Publicado: (2018)

Cathepsin K Mutation—A Subtle Clinical Presentation
por: Nandipati, Venkata Sandeep, et al.
Publicado: (2022)

Serum and Synovial Levels of Cathepsin G and Cathepsin K in Patients with Psoriatic Arthritis and Their Correlation with Disease Activity Indices
por: Popova-Belova, Stanislava Dimitrova, et al.
Publicado: (2023)

Biomarkers and Diagnostic Testing for Renal Disease in Sjogren's Syndrome
por: Ramponi, Giacomo, et al.
Publicado: (2020)

Mechanisms With Clinical Implications for Atrial Fibrillation–Associated Remodeling: Cathepsin K Expression, Regulation, and Therapeutic Target and Biomarker
por: Fujita, Masaya, et al.
Publicado: (2013)

IL8 and Cathepsin B as Melanoma Serum Biomarkers
por: Zhang, Hongtao, et al.
Publicado: (2011)

Cathepsin Z as a novel potential biomarker for osteoporosis
por: Dera, Ayed A., et al.
Publicado: (2019)

The Expression and Activity of Cathepsins D, H and K in Asthmatic Airways
por: Faiz, Alen, et al.
Publicado: (2013)

Increased Serum Cathepsin K in Patients with Coronary Artery Disease
por: Li, Xiang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a2r6ioc6720s8m6j5dfhnm2dis